ETN
69
2
DLTR
44
-6
FCX
40
5
SCHW
42
2
NDAQ
50
4
EQIX
59
2
ABT
57
3
PH
57
4
VTR
35
4
DFS
68
-2
AIG
32
-3
WBA
43
-5
MHK
33
3
RHI
40
-3
AFL
42
7
BDX
65
2
CA
16
-6
GIS
34
2
NAVI
35
-5
CNX
49
7
ETN
69
2
DLTR
44
-6
FCX
40
5
SCHW
42
2
NDAQ
50
4
EQIX
59
2
ABT
57
3
PH
57
4
VTR
35
4
DFS
68
-2
AIG
32
-3
WBA
43
-5
MHK
33
3
RHI
40
-3
AFL
42
7
BDX
65
2
CA
16
-6
GIS
34
2
NAVI
35
-5
CNX
49
7
Financhill
Back

Invesco NASDAQ 100 Index ETF - CAD hedged Vs. Janux Therapeutics Industry Stock Comparison

Sell
37

QQC.F.TO
Invesco NASDAQ 100 Index ETF - CAD hedged

Last Price:
$168.20
Seasonality Move:
4.87%
Sell
23

JANX
Janux Therapeutics

Last Price:
$50.53
Seasonality Move:
80.32%
Sell
37
Invesco NASDAQ 100 Index ETF - CAD hedged (QQC.F.TO) is a Sell

Is Invesco NASDAQ 100 Index ETF - CAD hedged a Buy, Sell or Hold?

  • The current Invesco NASDAQ 100 Index ETF - CAD hedged [QQC.F.TO] share price is $167.38. The Score for QQC.F.TO is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • QQC.F.TO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Janux Therapeutics (JANX) is a Sell

Is Janux Therapeutics a Buy, Sell or Hold?

  • The current Janux Therapeutics [JANX] share price is $50.82. The Score for JANX is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • JANX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

QQC.F.TO Stock Price Chart

What is Invesco NASDAQ 100 Index ETF - CAD hedged's stock price today?

JANX Stock Price Chart

What is Janux Therapeutics's stock price today?

  • The Janux Therapeutics share price today is $50.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and JANX is experiencing selling pressure, which indicates risk of future bearish movement.

QQC.F.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.22 Buy
Relative Strength Index (14 RSI): 47.81 Sell
Chaikin Money Flow: 3539 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (167.03 - 172.11) Sell
Bollinger Bands (100): (155.07 - 167.85) Buy

JANX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.52 Sell
Relative Strength Index (14 RSI): 41.88 Sell
Chaikin Money Flow: -1994706 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.74 - 62.68) Sell
Bollinger Bands (100): (44.76 - 56.7) Buy

QQC.F.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 167.95 Sell
20-day SMA: 169.87 Sell
50-day SMA: 166.59 Buy
200-day SMA: 155.54 Buy
8-day EMA: 168.26 Sell
20-day EMA: 168.59 Sell
50-day EMA: 166.46 Buy
200-day EMA: 155.54 Buy

JANX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.68 Sell
20-day SMA: 56.78 Sell
50-day SMA: 54.64 Sell
200-day SMA: 47.7 Buy
8-day EMA: 54.12 Sell
20-day EMA: 55.17 Sell
50-day EMA: 54.12 Sell
200-day EMA: 45.19 Buy

Invesco NASDAQ 100 Index ETF - CAD hedged Earnings Growth & QQC.F.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Janux Therapeutics Earnings Growth & JANX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.92 per share, and a decrease next year of $0.75 per share.

Invesco NASDAQ 100 Index ETF - CAD hedged Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Janux Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):